Expedited Development Enabled by RMAT and Breakthrough Therapy StatusClinical Trial Initiation in 2026, FDA Approval Target ...

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national procedure ...

Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent ...

The United States accounts for a significant share of the global remote patient monitoring (RPM) market. The U.S. RPM market ...

Samsung Biologics has agreed to acquire GlaxoSmithKline’s Human Genome Sciences and its two pharmaceutical manufacturing ...

SAN DIEGO, CA / ACCESS Newswire / December 24, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), ...

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient ...

Findings show Linus Health’s AI can indicate Alzheimer’s pathology before noticeable symptoms—enabling earlier action to help protect independence and preserve what makes us who we areBOSTON, December ...

Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug ...

CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this movie before. A company leans hard on a single product, rides momentum while it lasts, then scrambles when ...

Agreement with the U.S. government addresses prescription drug costs and encourages other wealthy nations to reward ...

The global dental laboratory services market is expected to register a compound annual growth rate (CAGR) of approximately 7% ...